Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q3

6523.TEDINET S100SW3M
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥256.7bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥89.9bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥265.1bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥94.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income−¥5.1bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income−¥9.3bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥21.4bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥10.9bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax−¥13.8bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥10.7bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥7.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥4.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)−¥11.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥8.7bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥3.4bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥2.2bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income−¥11.2bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income−¥8.7bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥3.6bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥2.2bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥541.0bnat 2023-12-31Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥569.9bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥416.7bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥124.3bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥138.8bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥124.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥137.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥43.9bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥59.4bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥28.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥17.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥11.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥31.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥32.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-88.72023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-69.072023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥27.332022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.692022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-88.72023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-69.072023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥27.072022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.532022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio23.0%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31¥1.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥7.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-12-31¥80.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-12-31¥80.3bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-12-31¥8.8bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-12-31¥79.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-12-31¥79.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-12-31¥4.9bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-12-31¥95.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-12-31¥95.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥11.6bn
—segment totalrevenue2023-04-01 → 2023-12-31¥254.9bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥254.9bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31¥1.8bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥1.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥13.0bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-12-31¥83.7bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-12-31¥83.7bn
jpcrp040300-q3r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-12-31¥19.7bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-12-31¥80.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-12-31¥80.4bn
jpcrp040300-q3r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-12-31¥6.3bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-12-31¥99.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-12-31¥99.2bn
jpcrp040300-q3r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.5bn
—segment totalrevenue2022-04-01 → 2022-12-31¥263.3bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥263.3bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥34.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 875
ItemContextValueUnit
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-695000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-7886000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-822000000JPY
Total transactions with owners IFRSPrior1YTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember47751000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember43422000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember23871000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-568000000JPY
Equity IFRSPrior1QuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior1QuarterInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember350000000JPY
Equity IFRSPrior1QuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember33000000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember15753000000JPY
Equity IFRSPrior2YearInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember333000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember16406000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember135374000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember690000000JPY
Equity IFRSPrior2YearInstant136065000000JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember3403000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember209000000JPY
Profit loss IFRSPrior1YTDDuration3612000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember6707000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember293000000JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember7887000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember7887000000JPY
Other comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember39000000JPY
Other comprehensive income IFRSPrior1YTDDuration7927000000JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember6707000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember293000000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember7887000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember11291000000JPY
Comprehensive income IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember248000000JPY
Comprehensive income IFRSPrior1YTDDuration11539000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember223000000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Issuance of new shares ss IFRSPrior1YTDDuration223000000JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-9201000000JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Dividends to owners of parent ss IFRSPrior1YTDDuration-9201000000JPY
Dividends to non controlling interests ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass